Harry Yang

Harry Yang has extensive work experience in the biotechnology and pharmaceutical industry. Harry is currently serving as the Vice President of Biometrics at Fate Therapeutics Inc since March 2020. Prior to this, Harry held the role of Executive Director and Head of AI and Analytics at AstraZeneca from March 2019 to October 2019. Harry also worked at MedImmune for over 21 years, starting as a Senior Director and later becoming the Head of Global Statistical Sciences. Before joining MedImmune, Harry worked as a Senior Statistician / Team Leader at BD. Harry started their career as a Postdoctoral Researcher at the Pittsburgh Cancer Institute.

Harry Yang attended the University of Pittsburgh from 1988 to 1994, where they obtained a Doctor of Philosophy (PhD) degree in Statistics.